.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Inflammatory bone defects significantly impact human health, especially when traditional stem cell therapies struggle against high oxidative stress. Recent breakthroughs in chiral nanozymes bone regeneration highlight the potential of metal-organic framework (MOF) nanozymes. Researchers inspired by deep-sea lobster hemocyanin have developed bionic Cu-Phe (D/L) nanozymes that effectively regulate the intracellular antioxidant defense system.
The study utilized a chiral engineering strategy to prepare Cu-Phe nanozymes using right-handed (D) and left-handed (L) phenylalanine ligands. Furthermore, the researchers observed that the Cu-Phe (L) variant clears reactive oxygen species (ROS) with remarkable efficiency. Consequently, this clearing of ROS protects cellular functionality and facilitates a shift in macrophage phenotype. Therefore, these nanozymes create a favorable environment for stem cell growth and tissue repair.
Moreover, the bionic nanozymes mimic natural superoxide dismutase (SOD) and catalase (CAT) activities. By reshaping the oxidative stress microenvironment, the Cu-Phe (L) nanozymes enhance osteoimmunomodulation. Specifically, they promote the differentiation of stem cells into bone-forming cells. Thus, this technology provides a rational roadmap for treating complex inflammatory bone defects using biomimetic materials.
Chiral nanozymes modulate oxidative stress by mimicking natural enzymes. Specifically, the left-handed Cu-Phe (L) variant effectively removes harmful reactive oxygen species, thereby allowing stem cells to differentiate into bone tissue more efficiently.
These nanozymes offer a targeted approach to treating bone defects characterized by chronic inflammation. Furthermore, they provide a more stable and effective alternative to traditional therapies in high-stress microenvironments.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Researchers developed chiral Cu-Phe nanozymes that mimic lobster hemocyanin to clear ROS and promote osteogenic differentiation in inflammatory bone defects...
6 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
